CellSource Co

CellSource Co Days Sales Outstanding

The Days Sales Outstanding (DSO) of CellSource Co (4880.T) as of Oct 27, 2026 is 32.72. In the previous year, Days Sales Outstanding (DSO) was 27.11 — a change of 20.66% (higher).

Days Sales Outstanding

32.72

YoY

20.66%

Last updated:

Days Sales Outstanding (DSO) of CellSource Co is 2025 32.72 . Days Sales Outstanding (DSO) of CellSource Co was 2024 27.11 . It decreases by 20.66% higher compared to the previous year.

The CellSource Co Days Sales Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Sales Outstanding
Date
Days Sales Outstanding
Jan 1, 2018
41.11 JPY
Jan 1, 2019
30.39 JPY
Jan 1, 2020
44.24 JPY
Jan 1, 2021
38.40 JPY
Jan 1, 2022
55.50 JPY
Jan 1, 2023
29.25 JPY
Jan 1, 2024
27.11 JPY
Jan 1, 2025
32.72 JPY
The CellSource Co Days Sales Outstanding history
YEARDays Sales OutstandingYoY
32.72+20.66%
27.11-7.31%
29.25-47.29%
55.50+44.52%
38.40-13.21%
44.24+45.60%
30.39-26.08%
41.11+17.15%
35.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Days Sales Outstanding (DSO) of CellSource Co is 32.72 in 2025.

Days Sales Outstanding (DSO) of CellSource Co changed from 27.11 to 32.72, representing a 20.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Sales Outstanding (DSO) CellSource Co since 2006 – with annual values, charts, and detailed analysis.

DSO measures the average number of days it takes to collect payment after a sale. Lower DSO indicates faster cash collection.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Sales Outstanding (DSO)'s CellSource Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Sales Outstanding (DSO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Sales Outstanding (DSO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CellSource Co

All Key Metrics — CellSource Co